| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROSEN CHRISTER | CEO and Chairman, Director, 10%+ Owner | C/O JUPITER NEUROSCIENCES, INC., 1001 NORTH US HYWAY 1, SUITE 504, JUPITER | /s/ Christer Rosen | 01 Jul 2025 | 0000902453 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JUNS | Common Stock | Options Exercise | $0 | +497,396 | +4.9% | $0.000000 | 10,591,406 | 02 Jun 2025 | Direct | F1 |
| transaction | JUNS | Common Stock | Options Exercise | $0 | +476,070 | +4.5% | $0.000000 | 11,067,476 | 02 Jun 2025 | Direct | F2 |
| transaction | JUNS | Common Stock | Purchase | $176 | +166 | +0% | $1.06 | 11,067,642 | 27 Jun 2025 | Direct | |
| transaction | JUNS | Common Stock | Purchase | $980 | +1,000 | +0.01% | $0.9800 | 11,068,642 | 30 Jun 2025 | Direct | |
| transaction | JUNS | Common Stock | Purchase | $2,020 | +2,000 | +0.02% | $1.01 | 11,070,642 | 30 Jun 2025 | Direct | |
| transaction | JUNS | Common Stock | Purchase | $1,479 | +1,450 | +0.01% | $1.02 | 11,072,092 | 30 Jun 2025 | Direct | |
| transaction | JUNS | Common Stock | Purchase | $721 | +700 | +0.01% | $1.03 | 11,072,792 | 30 Jun 2025 | Direct | |
| transaction | JUNS | Common Stock | Purchase | $1,560 | +1,500 | +0.01% | $1.04 | 11,074,292 | 30 Jun 2025 | Direct | |
| transaction | JUNS | Common Stock | Purchase | $1,050 | +1,000 | +0.01% | $1.05 | 11,075,292 | 30 Jun 2025 | Direct |
| Id | Content |
|---|---|
| F1 | Represents Restricted Stock Units that vested upon expiration of the lock-up period. |
| F2 | Represents Restricted Stock Awards that vested upon expiration of the lock-up period. |